References
- Koch, A.E. Angiogenesis: implications for rheumatoid arthritis. ARTHRITIS & RHEUMATISM 41: 951-962, 1998 https://doi.org/10.1002/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D
- Wolfe, F., Hawley, D.J. The longterm outcomes of rheumatoid arthritis: work disability: a prospective 18 year study of 823 patients. Journal of Rheumatology 25: 2108-2117, 1998
- Feldmann, M., Brennan, F.M., Maini, R.N. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14: 397-440, 1996 https://doi.org/10.1146/annurev.immunol.14.1.397
- Chinh, N., Tran, Steven, K. Lundy, David, A. Fox. Synovial biology and T cells in rheumatoid arthritis. Pathophysiology 12: 183-189, 2005 https://doi.org/10.1016/j.pathophys.2005.07.005
- Mary, E., Morgan, Roel of Flierman, Leonie M. van Duivenvoorde, Hendrik J. Witteveen, Willem van Ewijk, Jacob M. van Laar, Rene R.P. de Vries, and Rene E.M. Toes. Effective Treatment of Collagen-Induced Arthritis by Adoptive Transfer of CD25 Regulatory T Cells. arthritis & rheumatism 52: 2212-2221, 2005 https://doi.org/10.1002/art.21195
- Kim, H.M., Kim, M.J., Li, E., Lyu, Y.S., Hwang, C.Y., An, N.H. The nitric oxide-producing properties of Solanum lyratum. Journal of Ethopharmacology 67: 163-169, 1999 https://doi.org/10.1016/S0378-8741(99)00011-2
- Lee, Y.Y., Hsu, F.L., Nohara, T. Two new soladulcidine glycosides from Solanum lyratum. Chemical Pharmaceutical Bullutin 45: 1381-1382, 1997 https://doi.org/10.1248/cpb.45.1381
- Kang, B., Lee, E., Hong, I., Lee, J., Kin, H. Abolition of anaphylactic shock by Solanum lyratum Thunb. Int. J. Immunopharmacol. 19: 729, 1997 https://doi.org/10.1016/S0192-0561(97)00035-0
- Sun, L.X., Fu, W.W., Ren, J., Xu, L., Bi, K.S., Wanq, M.W. Cytotoxic constituents from Solanum lyratum. Arch Pharm Res. 29: 135-139, 2006 https://doi.org/10.1007/BF02974274
- Sun, L.X., Fu, W.W., Li, W., Bi, K.S., Wanq, M.W. Diosgenin glucuronides from Solanum lyratum and their cytotoxicity against tumor cell lines.. Z Naturforsch 61(3-4):171-176, 2006
- Kremer, J.M., Westhovens, R., Leon, M., Di Giorgio, E., Alten, R., Steinfeld, S. et al.. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4 Ig. The New England Journal of Medicine 349: 1907-1915, 2003 https://doi.org/10.1056/NEJMoa035075
- Luross, J.A., Williams, N.A. The genetic and immunopathological processes underlying collagen-induced arthritis. Immunology 103: 407-416, 2001 https://doi.org/10.1046/j.1365-2567.2001.01267.x
- Wooley, P.H., Chapedelaine, J.M. Immunogenetics of collagen-induced arthritis. Critical Reviews in Immunology 8: 1-22, 1987
- Janossy, G., Duke, O., Poulter, L.W., Panayi G., Bofill M. and Goldstein G. rheumatoid arthritis : a disease of t-lymphocyte/macrophage immunoregulation Lancet 318: 839, 1981 https://doi.org/10.1016/S0140-6736(81)91107-7
- Quayle, A.J., Chomarat, P., Miossec, P., Kjeldsen-Kragh, J., Forre, O. and Natvig, J.B. Rheumatoid inflammatory T-cell clones express mostly Th1 but also Th2 and mixed (Th0-like) cytokine patterns. Scandinavian Journal of Immunology. 38: 75-82, 1993
- Dolhan, R.J. E.M., van der Heiden, A.N., ter Haar, N.T., Breedveld, F.C. and Miltenburg, A.M.M. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. ARTHRITIS & RHEUMATISM. 39: 1961-1969, 1996 https://doi.org/10.1002/art.1780391204
- Kadowaki, K.M., Matsuno, H., Tsuji, H., Tunru, I. CD4+ T cells from collagen-induced arthritic mice are essential to transfer arthritis into severe combined immunodeficient mice. Clinical andExperimental Immunology 97: 212-218, 1994
- Williams, R.O., Whyte, A., Waldmann, H. Resistance to collageninduced arthritis in DBA/1 mice by intraperitoneal administration of soluble type II collagen involves both CD4+ and CD8+ T lymphocytes. Autoimmunity 4: 237-245, 1989 https://doi.org/10.3109/08916938909014700
- Takemura, S., Klimiuk, P.A., Braun, A. et al. T cell activation in rheumatoid synovium is B cell dependent. Journal of Immunology 167: 4710-4718, 2001 https://doi.org/10.4049/jimmunol.167.8.4710
- Paolo Serafini, Carmela De Santo, Ilaria Marigo, Sara Cingarlini, Luigi Dolcetti, Giovanna Gallina, Paola Zanovello, Vincenzo Bronte. Derangement of immune responses by myeloid suppressor cells. Cancer Immunol Immunother 53: 6472, 2004
- Jean-Michel Dayer. The process of identifying and understanding cytokines: from basic studies to treating rheumatic diseases. Best Practice & Research Clinical Rheumatology 18(1):3145, 2004